Considering ACLAbs and Antiβ2-GPIAbs, only one of the patients (with APS type II but undetectable 21-hydroxylase antibodies) has been positive for antibodies against beta-2-Glycoprotein I. However, the woman has not developed clinically apparent antiphospholipid syndrome (APhS) yet. Here, APOH is linked to antiphospholipid syndrome.